1-2-3 Magic treatment for families with children with attention deficit hyperactivity disorder (ADHD)

A randomised wait-list controlled trial evaluating 1-2-3 Magic and its effectiveness on families with children with ADHD

Registry ID
ISRCTN15281572
Source registry
ISRCTN
Status
No longer recruiting
Study type
INTERVENTIONAL
Sponsor
University College London
Enrollment
100
Start date
2021-12-01
Completion date
2023-05-30
Last update
2026-08-17

Conditions

Summary

Behavioural parenting programme for parents with children with ADHD

Detailed description

To test the effectiveness of the 1-2-3 Magic Programme administered online via Zoom, a randomised waiting-list controlled trial has been designed to evaluate whether 1-2-3 Magic can reduce parents’ perceived severity of their child’s symptoms of ADHD, thereby building parent confidence and improving familial relationships. 84 parents of children with diagnosed ADHD, under the age of 12, will attend six sessions of two and a half hours per session over a course of 6 weeks. The sessions will consist of training in behavioural management techniques using the key tools “1-2-3 Magic” and the “Evaluation tools on parenting.” The 1-2-3 Magic programme has a duration of 6 weeks, with one session per week. Arm 1: Arm 1 will start their intervention within the same month of the baseline and just after the baseline measurement in month 1. Arm 1 will complete questionnaires at six timepoints. Arm 1’s baseline questionnaire will also pose as their pre-intervention questionnaire: baseline/month 1 (pre-intervention), 6 weeks after pre-intervention, month 3, month 6, month 9 and month 12. Arm 2: Arm 2 will start their intervention 3 months after the baseline in March 2022. Arm 2 serve as the control group for 3 months. Arm 2 will complete questionnaires at 6 timelines: baseline (month 1), month 3 (pre-intervention), 6 weeks after pre-intervention, months 6, months 9 and months 12. Arm 3: Arm 3 will start their intervention 6 months after the baseline, in July 2022. Arm 3 serve as the control group for 6 months. Arm 3 will complete questionnaires at 6 timelines: baseline (month 1), months 3, months 6 (pre-intervention), 6 weeks after pre-intervention, months 9 and months 12. Randomisation will be conducted via online random allocators.

Interventions

Inclusion criteria

Current participant inclusion criteria as of 25/07/2023: 1. Parents of children aged 12 years old and under 2. Parents of children with an official diagnosis of ADHD 3. Parents who speak, read, and write proficient English Previous participant inclusion criteria: 1. Parents of children under the age of 12 years 2. Parents of children with an official diagnosis of ADHD 3. Parents who speak, read, and write proficient English

Exclusion criteria

Individual cannot read, write or speak proficient English

Locations

Related clinical trials

View on source registry